首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1555536

药物混悬液市场，按类型、适应症、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Pharmaceutical Suspension Market, By Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年08月20日 | 出版商:

AnalystView Market Insights | 英文 392 Pages | 商品交期: 2-3个工作天内

价格

简介目录

报告要点

2023年药物混悬剂市场规模为563.4532亿美元，2024年至2032年复合年增长率为4.3%。

药物混悬液市场-市场动态

药物传输技术的进步和研发投入的增加预计将推动市场需求

药物传递系统和製剂技术的创新提高了混悬剂的功效和稳定性。用于製造稳定、高品质混悬剂的改良技术有助于满足复杂药物的需求，从而促进市场成长。糖尿病、癌症和呼吸系统疾病等慢性病发病率的增加推动了对各种药物製剂（包括混悬剂）的需求。这些製剂对于需要液体形式药物的患者特别有用。此外，製造流程的进步，例如更好的混合和研磨技术，提高了药物悬浮液的品质和一致性，使其对製造商和消费者都更具吸引力。

製药公司增加研发投资以创造新的和改进的配方推动了市场成长。这包括开发新药混悬剂或改进现有产品。此外，由于消费者对方便易得的治疗的偏好，对悬浮液形式的非处方药（OTC）药物（例如抗酸剂、止咳糖浆和止痛药）的需求持续成长。

药物混悬液市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.3% 左右的复合年增长率成长

根据类型细分，由于其快速、直接的给药途径，预计注射剂细分市场将在 2023 年显示最大的市场份额。

根据适应症细分，由于抗癌药物的大量供应，癌症细分市场是 2023 年的主要适应症。

根据最终用户细分，由于癌症和慢性疾病的盛行率不断增加，医院细分市场将在 2023 年成为领先的最终用户细分市场。

按地区划分，由于混悬剂药物的广泛供应，北美将成为 2023 年的主要收入来源。

药物混悬液市场-細項分析：

全球药物混悬剂市场根据类型、适应症、最终用户和地区进行细分。

市场依类型分为三类：口服、肠胃外和其他。注射剂细分市场占据主导地位。肠外药物配方的进步及其更广泛的采用主要推动了市场的成长。

根据适应症，市场分为五类：癌症、胃肠道、神经系统、传染病等。癌症领域占市场主导地位。治疗领域和技术的不断发展正在刺激细分市场的成长。

根据最终用户，市场分为三类：医院、诊所和其他。医院领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。改善的慢性病治疗和疗法正在促进细分市场的成长。

药物混悬液市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。亚太地区因其人口众多、医疗保健支出不断增加以及慢性病患病率不断上升而成为一个主要市场。该地区的中国、印度和日本等国家都是重要的药品製造中心。与其他地区相比，中东和非洲市场相对不发达，但由于医疗保健机会的增加和对各种治疗方案的认识不断提高，人们的兴趣与日俱增。

药物混悬液市场-竞争格局：

药物混悬剂市场充满活力，持续的进步和竞争策略塑造了其发展。利用技术创新和策略合作伙伴关係的公司。领先的公司注重创新，以使其产品脱颖而出并保持竞争优势。这包括开发新配方、改良药物输送系统以及投资研发。公司经常与学术机构和研究组织合作，推进药物传输科学并开发创新的混悬液配方。

2023年8月，全球领先的生物製药公司默克宣布批准ERVEBO的扩大适应症，用于治疗一种名为扎伊尔伊波拉病毒的疾病。

2023 年 11 月，梯瓦製药工业公司 (Teva Pharmaceutical Industries) 和Royalty Pharma plc 合作加速其临床研究计画。

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美药物混悬液主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按类型）
- 北美市场规模和预测（按指标）
- 北美市场规模和预测（按最终用户）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲药物混悬剂主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按类型）
- 欧洲市场规模与预测（按指标）
- 欧洲市场规模和预测（按最终用户）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区药物混悬剂主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按类型）
- 亚太地区市场规模与预测（依指标）
- 亚太地区市场规模和预测（按最终用户）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲药物混悬剂主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按类型）
- 拉丁美洲市场规模与预测（按指标）
- 拉丁美洲市场规模和预测（按最终用户）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲药混悬剂主要生产商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按类型）
- 中东和非洲市场规模及预测（依指标）
- 中东和非洲市场规模及预测（按最终用户）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 药物混悬液产业

竞争仪表板
公司简介
- Pfizer Inc.
- Johnson & Johnson
- Novartis AG
- GlaxoSmithKline (GSK)
- Sanofi
- Roche
- Merck & Co., Inc.
- Bristol-Myers Squibb
- AbbVie Inc.
- AstraZeneca
- Amgen Inc.
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Dr. Reddy's Laboratories
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法
参考
缩写
免责声明
联络我们

简介目录

Product Code: ANV3655

REPORT HIGHLIGHT

Pharmaceutical Suspension Market size was valued at USD 56,345.32 Million in 2023, expanding at a CAGR of 4.3% from 2024 to 2032.

A pharmaceutical suspension is a type of liquid dosage form used in medicine. It consists of solid particles dispersed throughout a liquid medium. Unlike solutions where the active ingredient is fully dissolved, in suspensions, the active ingredient remains undissolved and is suspended in the liquid.

Pharmaceutical Suspension Market- Market Dynamics

Advancement in drug delivery technologies and increasing R&D investment is expected to propel market demand

Innovations in drug delivery systems and formulation technologies enhance the efficacy and stability of suspensions. Improved technologies for creating stable, high-quality suspensions help meet the needs of complex medications, which is boosting market growth. The increasing incidence of chronic conditions such as diabetes, cancer, and respiratory diseases drives the demand for various pharmaceutical formulations, including suspensions. These formulations are particularly useful for patients who need medication in a liquid form. Further, Advances in manufacturing processes, such as better mixing and milling techniques, improve the quality and consistency of pharmaceutical suspensions, making them more attractive to both manufacturers and consumers.

Increased investment in research and development by pharmaceutical companies to create new and improved formulations drives market growth. This includes developing suspensions for new drugs or improving existing products. Moreover, the demand for over the counter (OTC) medications in suspension form, such as antacids, cough syrups, and pain relievers, continues to grow, driven by consumer preference for convenient and accessible treatments.

Pharmaceutical Suspension Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2024-2032)

Based on Type segmentation, the parenteral segment was predicted to show maximum market share in the year 2023, owing to its rapid & direct route for drug delivery.

Based on Indication segmentation, the cancer segment was the leading Indication in 2023, owing to the large availability of cancer drugs.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, owing to the increasing prevalence of cancer, chronic disorders.

Based on region, North America was the leading revenue generator in 2023, due to the wide availability of suspension-based medications.

Pharmaceutical Suspension Market- Segmentation Analysis:

The Global Pharmaceutical Suspension Market is segmented based on Type, Indication, End User, and Region.

The market is divided into three categories based on Type: oral, parenteral, and others. The parenteral segment dominates the market. Advancements in parenteral drug formulations and their greater adoption are mainly boosting market growth.

The market is divided into five categories based on Indication: cancer, gastrointestinal, neurological, infectious disease, and others. The cancer segment dominates the market. The growing development in therapeutic areas and technology is stimulating segment growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The improved chronic disease treatment and therapy are proliferating segment growth.

Pharmaceutical Suspension Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is a major market due to its large population, rising healthcare expenditure, and increasing prevalence of chronic diseases. The region has countries like China, India, and Japan which are significant hubs for pharmaceutical manufacturing. The Middle East & Africa market is relatively underdeveloped compared to other regions, but there is growing interest due to increasing healthcare access and rising awareness of various treatment options.

Pharmaceutical Suspension Market- Competitive Landscape:

The pharmaceutical suspension market is significantly dynamic, with ongoing advancements and competitive strategies shaping its evolution. Companies that leverage technological innovation, and strategic partnerships. Leading companies focus on innovation to differentiate their products and maintain a competitive edge. This includes developing new formulations, improving drug delivery systems, and investing in research and development. Companies often collaborate with academic institutions and research organizations to advance the science of drug delivery and develop innovative suspension formulations.

In August 2023, Merck & Co., Inc., a leading global biopharmaceutical company, announced the approval of an expanded indication for ERVEBO for the disease called Zaire ebolavirus.

In November 2023, Teva Pharmaceutical Industries and Royalty Pharma plc, partnered to accelerate their clinical research program.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL SUSPENSION MARKET KEY PLAYERS

Pfizer Inc.
Johnson & Johnson
Novartis AG
GlaxoSmithKline (GSK)
Sanofi
Roche
Merck & Co., Inc.
Bristol-Myers Squibb
AbbVie Inc.
AstraZeneca
Amgen Inc.
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Dr. Reddy's Laboratories
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

Oral
Parenteral
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

Cancer
Gastrointestinal
Neurological
Infectious Disease
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospitals
Clinics
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Pharmaceutical Suspension Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Pharmaceutical Suspension Market Snippet by Type
- 2.1.2. Pharmaceutical Suspension Market Snippet by Indication
- 2.1.3. Pharmaceutical Suspension Market Snippet by End User
- 2.1.4. Pharmaceutical Suspension Market Snippet by Country
- 2.1.5. Pharmaceutical Suspension Market Snippet by Region
2.2. Competitive Insights

3. Pharmaceutical Suspension Key Market Trends

3.1. Pharmaceutical Suspension Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Pharmaceutical Suspension Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Pharmaceutical Suspension Market Opportunities
3.4. Pharmaceutical Suspension Market Future Trends

4. Pharmaceutical Suspension Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Pharmaceutical Suspension Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Pharmaceutical Suspension Market Landscape

6.1. Pharmaceutical Suspension Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Suspension Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Oral
- 7.1.3. Parenteral
- 7.1.4. Others

8. Pharmaceutical Suspension Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
- 8.1.2. Cancer
- 8.1.3. Gastrointestinal
- 8.1.4. Neurological
- 8.1.5. Infectious Disease
- 8.1.6. Others

9. Pharmaceutical Suspension Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Clinics
- 9.1.4. Others

10. Pharmaceutical Suspension Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Pharmaceutical Suspension Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Pharmaceutical Suspension Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Pharmaceutical Suspension Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Pharmaceutical Suspension Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Pharmaceutical Suspension Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Suspension Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Pfizer Inc.
- 11.2.2. Johnson & Johnson
- 11.2.3. Novartis AG
- 11.2.4. GlaxoSmithKline (GSK)
- 11.2.5. Sanofi
- 11.2.6. Roche
- 11.2.7. Merck & Co., Inc.
- 11.2.8. Bristol-Myers Squibb
- 11.2.9. AbbVie Inc.
- 11.2.10. AstraZeneca
- 11.2.11. Amgen Inc.
- 11.2.12. Glenmark Pharmaceuticals
- 11.2.13. Teva Pharmaceutical Industries Ltd.
- 11.2.14. Mylan N.V.
- 11.2.15. Dr. Reddy's Laboratories
- 11.2.16. Others